Clinical Trials Browser

NIH × Interventional × MAGEA3 protein, human × Clear all

NCT01307618 2016-10-24

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Phase 2 Terminated

10 enrolled 8 charts

Melanoma

NCT00003792 2013-06-26

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1 Completed

Melanoma